Abstract
Spurred by increasing competition in the pharmaceutical industry, some drug companies would like to be allowed to advertise their prescription drugs to the general public as well as to health professionals. The Food and Drug Administration, concerned about the legal and ethical implications of direct-to-consumer advertising, has asked for time to study the proposal.

This publication has 0 references indexed in Scilit: